palmitic acid has been researched along with Dyslipidemia in 12 studies
Palmitic Acid: A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.
hexadecanoic acid : A straight-chain, sixteen-carbon, saturated long-chain fatty acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent liver diseases without effective pharmacological intervention." | 5.72 | Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling. ( Jiang, R; Liang, L; Meng, S; Ye, S; Zhou, J; Zhou, X, 2022) |
| "Ceramide plays pathogenic roles in nonalcoholic fatty liver disease (NAFLD) via multiple mechanisms, and as such inhibition of ceramide de novo synthesis in the liver may be of therapeutically beneficial in patients with NAFLD." | 2.90 | Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis. ( Fan, JG; Hu, CX; Liu, XL; Pan, Q; Qiao, L; Xin, FZ; Xu, GW; Yang, RX; Zeng, J; Zhang, RN; Zhao, ZH; Zhou, D, 2019) |
| "Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent liver diseases without effective pharmacological intervention." | 1.72 | Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling. ( Jiang, R; Liang, L; Meng, S; Ye, S; Zhou, J; Zhou, X, 2022) |
| "Patients with psoriasis are frequently complicated with metabolic syndrome; however, it is not fully understood how obesity and dyslipidemia contribute to the pathogenesis of psoriasis." | 1.72 | Obesity and Dyslipidemia Synergistically Exacerbate Psoriatic Skin Inflammation. ( Akagi, T; Hiramatsu-Asano, S; Ikeda, K; Iseki, M; Ishihara, K; Kaneto, H; Morita, Y; Morizane, S; Mukai, T; Tachibana, K; Wada, J; Yahagi, A, 2022) |
| " In wild type and CHOP(-/-) mice treated with EtOH and high fat diet (HFD), EtOH worsened the HFD-induced liver injury and dyslipidemia, while CHOP knockout blocked toxic effects of EtOH and PA." | 1.42 | Ethanol promotes saturated fatty acid-induced hepatoxicity through endoplasmic reticulum (ER) stress response. ( Cao, W; Lu, J; Ma, YX; Wang, CF; Wang, XN; Wu, XD; Yi, HW, 2015) |
| "Palmitic acid was one of the saturated fatty acids found to be significantly elevated in patients compared with control subjects (P = 0." | 1.42 | Increased RhoA/Rho-Kinase Activity and Markers of Endothelial Dysfunction in Young Adult Subjects with Metabolic Syndrome. ( Leguina-Ruzzi, A; Mezzano, D; Pereira, J; Pereira-Flores, K; Sáez, CG; Valderas, JP; Velarde, V, 2015) |
| "Dyslipidemia is common in patients with HIV infection." | 1.33 | Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia. ( Cade, WT; DeMoss, A; Fontana, L; Klein, S; Laciny, E; Patterson, BW; Powderly, WG; Reeds, DN; Yarasheski, KE, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, L | 1 |
| Ye, S | 1 |
| Jiang, R | 1 |
| Zhou, X | 1 |
| Zhou, J | 1 |
| Meng, S | 1 |
| Ikeda, K | 1 |
| Morizane, S | 1 |
| Akagi, T | 1 |
| Hiramatsu-Asano, S | 1 |
| Tachibana, K | 1 |
| Yahagi, A | 1 |
| Iseki, M | 1 |
| Kaneto, H | 1 |
| Wada, J | 1 |
| Ishihara, K | 1 |
| Morita, Y | 1 |
| Mukai, T | 1 |
| Yang, RX | 1 |
| Pan, Q | 1 |
| Liu, XL | 1 |
| Zhou, D | 1 |
| Xin, FZ | 1 |
| Zhao, ZH | 1 |
| Zhang, RN | 1 |
| Zeng, J | 1 |
| Qiao, L | 1 |
| Hu, CX | 1 |
| Xu, GW | 1 |
| Fan, JG | 1 |
| Wu, YK | 1 |
| Hu, LF | 1 |
| Lou, DS | 1 |
| Wang, BC | 1 |
| Tan, J | 1 |
| Murphy, BA | 1 |
| Tadin-Strapps, M | 1 |
| Jensen, K | 1 |
| Mogg, R | 1 |
| Liaw, A | 1 |
| Herath, K | 1 |
| Bhat, G | 1 |
| McLaren, DG | 1 |
| Previs, SF | 1 |
| Pinto, S | 1 |
| Rumora, AE | 1 |
| Lentz, SI | 1 |
| Hinder, LM | 1 |
| Jackson, SW | 1 |
| Valesano, A | 1 |
| Levinson, GE | 1 |
| Feldman, EL | 1 |
| Bi, L | 1 |
| Chiang, JY | 1 |
| Ding, WX | 1 |
| Dunn, W | 1 |
| Roberts, B | 1 |
| Li, T | 1 |
| Li, Y | 1 |
| Lu, Z | 1 |
| Zhang, X | 1 |
| Yu, H | 1 |
| Kirkwood, KL | 1 |
| Lopes-Virella, MF | 1 |
| Huang, Y | 1 |
| Yi, HW | 1 |
| Ma, YX | 1 |
| Wang, XN | 1 |
| Wang, CF | 1 |
| Lu, J | 1 |
| Cao, W | 1 |
| Wu, XD | 1 |
| Leguina-Ruzzi, A | 1 |
| Pereira, J | 1 |
| Pereira-Flores, K | 1 |
| Valderas, JP | 1 |
| Mezzano, D | 1 |
| Velarde, V | 1 |
| Sáez, CG | 1 |
| Reeds, DN | 1 |
| Yarasheski, KE | 1 |
| Fontana, L | 1 |
| Cade, WT | 1 |
| Laciny, E | 1 |
| DeMoss, A | 1 |
| Patterson, BW | 1 |
| Powderly, WG | 1 |
| Klein, S | 1 |
| Koonen, DP | 1 |
| Jacobs, RL | 1 |
| Febbraio, M | 1 |
| Young, ME | 1 |
| Soltys, CL | 1 |
| Ong, H | 1 |
| Vance, DE | 1 |
| Dyck, JR | 1 |
1 trial available for palmitic acid and Dyslipidemia
| Article | Year |
|---|---|
Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Topics: Adult; Animals; Autophagy; Carnitine O-Palmitoyltransferase; Case-Control Studies; Ceramides; Diet, | 2019 |
11 other studies available for palmitic acid and Dyslipidemia
| Article | Year |
|---|---|
Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cytokines | 2022 |
Obesity and Dyslipidemia Synergistically Exacerbate Psoriatic Skin Inflammation.
Topics: Animals; Dermatitis; Dyslipidemias; Humans; Inflammation; Interleukin-17; Keratinocytes; Leptin; Mic | 2022 |
Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK.
Topics: Animals; Cell Line; Diet, High-Fat; Dual-Specificity Phosphatases; Dyslipidemias; Feeding Behavior; | 2020 |
siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeys.
Topics: Animals; Biomarkers; Cholesterol; Dyslipidemias; Female; Intracellular Signaling Peptides and Protei | 2017 |
Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Dyslipidemias; Energy Metabolism; Ganglia | 2018 |
Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Diabetes Mellitus, Experimental; Down-Regulation; Dy | 2013 |
Metabolic syndrome exacerbates inflammation and bone loss in periodontitis.
Topics: Aggregatibacter actinomycetemcomitans; Alveolar Bone Loss; Animals; Chemokine CCL2; Cytokines; Diet, | 2015 |
Ethanol promotes saturated fatty acid-induced hepatoxicity through endoplasmic reticulum (ER) stress response.
Topics: Activating Transcription Factor 4; Animals; Apoptosis; Caspase 3; Chemical and Drug Induced Liver In | 2015 |
Increased RhoA/Rho-Kinase Activity and Markers of Endothelial Dysfunction in Young Adult Subjects with Metabolic Syndrome.
Topics: Adult; Age Factors; Biomarkers; Case-Control Studies; Cholesterol, HDL; Cross-Sectional Studies; Dys | 2015 |
Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia.
Topics: Adiponectin; Adipose Tissue; Adult; Blood Glucose; Body Composition; Cholesterol, HDL; Dyslipidemias | 2006 |
Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity.
Topics: Animals; CD36 Antigens; Cells, Cultured; Dyslipidemias; Energy Intake; Fatty Acids; Glucose Toleranc | 2007 |